CHICAGO--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John ...

William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John Ivey and B.T. Remmert as ...

William Blair also issued estimates for Medpace’s Q2 2025 earnings at $3.09 EPS and FY2026 earnings at $13.89 EPS. Get Medpace alerts: Other research analysts also recently issued reports about ...

On Friday, William Blair analysts downgraded WEX Inc. (NYSE:WEX) from Outperform to Market Perform. The firm expressed concerns about the company's competitive edge and capital allocation strategies.

Stephanie Braming, global head of William Blair Investment Management, plans to retire in the fourth quarter, a news release said. She joined the Chicago-based firm in 2004 and served as portfolio ...

CHICAGO, February 10, 2025--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named ...

William Blair analyst Dylan Becker upgraded Manhattan Associates (MANH) to Outperform from Market Perform without a price target The firm says its cloud model analysis and additional color on the ...

William Blair also issued estimates for AptarGroup’s Q2 2025 earnings at $1.42 EPS, Q4 2025 earnings at $1.42 EPS, Q2 2026 earnings at $1.63 EPS, Q3 2026 earnings at $1.78 EPS and Q4 2026 ...

William Blair downgraded Sprinklr (CXM) to Market Perform from Outperform without a price target after the company announced a 15% global workforce reduction. While expectations are low for the ...

On Monday, William Blair reaffirmed a Market Perform rating on Kenvue Inc (NYSE:KVUE), a consumer health company with a market capitalization of $38.69 billion. According to InvestingPro data ...

We recently compiled a list of the 10 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other ...

William Blair downgraded Charles River Laboratories to market perform from outperform citing a likely decline in early-stage R&D spending from large pharmaceutical companies. Analysts Max Smock ...